133 related articles for article (PubMed ID: 11330342)
1. Blocking effects of the antiarrhythmic drug propafenone on the HERG potassium channel.
Mergenthaler J; Haverkamp W; Hüttenhofer A; Skryabin BV; Musshoff U; Borggrefe M; Speckmann EJ; Breithardt G; Madeja M
Naunyn Schmiedebergs Arch Pharmacol; 2001 Apr; 363(4):472-80. PubMed ID: 11330342
[TBL] [Abstract][Full Text] [Related]
2. Regulation of antiarrhythmic drug propafenone effects on the c-type Kv1.4 potassium channel by PHo and K+.
Wang Z; Wang S; Li J; Jiang X; Wang N
J Korean Med Sci; 2009 Feb; 24(1):84-91. PubMed ID: 19270818
[TBL] [Abstract][Full Text] [Related]
3. Effects of propafenone and its main metabolite, 5-hydroxypropafenone, on HERG channels.
Arias C; González T; Moreno I; Caballero R; Delpón E; Tamargo J; Valenzuela C
Cardiovasc Res; 2003 Mar; 57(3):660-9. PubMed ID: 12618228
[TBL] [Abstract][Full Text] [Related]
4. Direct block of hERG potassium channels by the protein kinase C inhibitor bisindolylmaleimide I (GF109203X).
Thomas D; Hammerling BC; Wimmer AB; Wu K; Ficker E; Kuryshev YA; Scherer D; Kiehn J; Katus HA; Schoels W; Karle CA
Cardiovasc Res; 2004 Dec; 64(3):467-76. PubMed ID: 15537500
[TBL] [Abstract][Full Text] [Related]
5. Acute effects of dronedarone on both components of the cardiac delayed rectifier K+ current, HERG and KvLQT1/minK potassium channels.
Thomas D; Kathofer S; Zhang W; Wu K; Wimmer AB; Zitron E; Kreye VA; Katus HA; Schoels W; Karle CA; Kiehn J
Br J Pharmacol; 2003 Nov; 140(5):996-1002. PubMed ID: 14517175
[TBL] [Abstract][Full Text] [Related]
6. Spironolactone and its main metabolite, canrenoic acid, block human ether-a-go-go-related gene channels.
Caballero R; Moreno I; González T; Arias C; Valenzuela C; Delpón E; Tamargo J
Circulation; 2003 Feb; 107(6):889-95. PubMed ID: 12591761
[TBL] [Abstract][Full Text] [Related]
7. Molecular site of action of the antiarrhythmic drug propafenone at the voltage-operated potassium channel Kv2.1.
Madeja M; Leicher T; Friederich P; Punke MA; Haverkamp W; Musshoff U; Breithardt G; Speckmann EJ
Mol Pharmacol; 2003 Mar; 63(3):547-56. PubMed ID: 12606761
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of the current of heterologously expressed HERG potassium channels by flecainide and comparison with quinidine, propafenone and lignocaine.
Paul AA; Witchel HJ; Hancox JC
Br J Pharmacol; 2002 Jul; 136(5):717-29. PubMed ID: 12086981
[TBL] [Abstract][Full Text] [Related]
9. Class III antiarrhythmic drugs block HERG, a human cardiac delayed rectifier K+ channel. Open-channel block by methanesulfonanilides.
Spector PS; Curran ME; Keating MT; Sanguinetti MC
Circ Res; 1996 Mar; 78(3):499-503. PubMed ID: 8593709
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of human ether-a-go-go-related gene K+ channel and IKr of guinea pig cardiomyocytes by antipsychotic drug trifluoperazine.
Choi SY; Koh YS; Jo SH
J Pharmacol Exp Ther; 2005 May; 313(2):888-95. PubMed ID: 15722405
[TBL] [Abstract][Full Text] [Related]
11. Blockade of the human ether-a-go-go-related gene potassium channel by ketanserin.
Tu DN; Zou AR; Liao YH; Du YM; Wang XP; Li L
Sheng Li Xue Bao; 2008 Aug; 60(4):525-34. PubMed ID: 18690396
[TBL] [Abstract][Full Text] [Related]
12. Kinetic modulation of HERG potassium channels by the volatile anesthetic halothane.
Li J; Correa AM
Anesthesiology; 2002 Oct; 97(4):921-30. PubMed ID: 12357160
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effects of berberine on IK1, IK, and HERG channels of cardiac myocytes.
Li BX; Yang BF; Zhou J; Xu CQ; Li YR
Acta Pharmacol Sin; 2001 Feb; 22(2):125-31. PubMed ID: 11741516
[TBL] [Abstract][Full Text] [Related]
14. Modulation of HERG potassium channels by extracellular magnesium and quinidine.
Po SS; Wang DW; Yang IC; Johnson JP; Nie L; Bennett PB
J Cardiovasc Pharmacol; 1999 Feb; 33(2):181-5. PubMed ID: 10028924
[TBL] [Abstract][Full Text] [Related]
15. Interactions of the antimalarial drug mefloquine with the human cardiac potassium channels KvLQT1/minK and HERG.
Kang J; Chen XL; Wang L; Rampe D
J Pharmacol Exp Ther; 2001 Oct; 299(1):290-6. PubMed ID: 11561091
[TBL] [Abstract][Full Text] [Related]
16. Protein kinase A-mediated phosphorylation of HERG potassium channels in a human cell line.
Wei Z; Thomas D; Karle CA; Kathöfer S; Schenkel J; Kreye VA; Ficker E; Wible BA; Kiehn J
Chin Med J (Engl); 2002 May; 115(5):668-76. PubMed ID: 12133532
[TBL] [Abstract][Full Text] [Related]
17. Open channel block of HERG K(+) channels by vesnarinone.
Kamiya K; Mitcheson JS; Yasui K; Kodama I; Sanguinetti MC
Mol Pharmacol; 2001 Aug; 60(2):244-53. PubMed ID: 11455010
[TBL] [Abstract][Full Text] [Related]
18. Norpropoxyphene-induced cardiotoxicity is associated with changes in ion-selectivity and gating of HERG currents.
Ulens C; Daenens P; Tytgat J
Cardiovasc Res; 1999 Dec; 44(3):568-78. PubMed ID: 10690289
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effects of the class III antiarrhythmic drug amiodarone on cloned HERG potassium channels.
Kiehn J; Thomas D; Karle CA; Schöls W; Kübler W
Naunyn Schmiedebergs Arch Pharmacol; 1999 Mar; 359(3):212-9. PubMed ID: 10208308
[TBL] [Abstract][Full Text] [Related]
20. A mechanism for the potential proarrhythmic effect of acidosis, bradycardia, and hypokalemia on the blockade of human ether-a-go-go-related gene (HERG) channels.
Lin C; Cvetanovic I; Ke X; Ranade V; Somberg J
Am J Ther; 2005; 12(4):328-36. PubMed ID: 16041196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]